°øÁö : µµÄìÁõ±Ç°Å·¡¼Ò JASDAQ ½ºÅÄ´Ùµå ½ÃÀå ½Å±Ô »óÀå °ü·Ã ¾È³»

Global Information
ȸ»ç¼Ò°³ | ¹®ÀÇ | ºñ±³¸®½ºÆ®

Ç÷°ü ½ºÅÙÆ® ½ÃÀå : ¼¼°è ¾÷°è ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2019-2027³â)

Vascular Stents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

¸®¼­Ä¡»ç Transparency Market Research
¹ßÇàÀÏ 2020³â 06¿ù »óǰ ÄÚµå 953654
ÆäÀÌÁö Á¤º¸ ¿µ¹® 231 Pages
°¡°Ý
US $ 5,795 £Ü 6,412,000 PDF (Single User License) help
1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº Copy & Paste°¡ °¡´ÉÇÕ´Ï´Ù. PDF Àμâ´Â °¡´ÉÇÏÁö¸¸, Àüü ÆäÀÌÁö Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿¡ ÁØÇÕ´Ï´Ù.
US $ 8,795 £Ü 9,732,000 PDF (Multi-user License)
US $ 11,795 £Ü 13,052,000 PDF (Corporate License) help
±â¾÷ ³» ¸ðµç ºÐµéÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÀÌ¿ë Àοø¼ö Á¦ÇÑÀº ¾ø½À´Ï´Ù. PDF ÆÄÀÏÀº Copy & Paste°¡ °¡´ÉÇÕ´Ï´Ù. ÀμâȽ¼ö¿¡ Á¦ÇÑÀº ¾øÀ¸³ª, Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿¡ ÁØÇÕ´Ï´Ù.


Ç÷°ü ½ºÅÙÆ® ½ÃÀå : ¼¼°è ¾÷°è ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2019-2027³â) Vascular Stents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027
¹ßÇàÀÏ : 2020³â 06¿ù ÆäÀÌÁö Á¤º¸ : ¿µ¹® 231 Pages

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹®¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹®¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ Ç÷°ü ½ºÅÙÆ® ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ¼¼°è ½ÃÀå °³¿ä, ÀüüÀûÀÎ ¸ÅÃâ, CAGR°ú ¿¹Ãø, ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ, °¢ ºÎ¹®¡¤Áö¿ªº° ½ÃÀå µî¿¡ ´ëÇÑ ºÐ¼®, ÁÖ¿ä ±â¾÷ °³¿ä¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå °¡Á¤°ú Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à : ¼¼°èÀÇ Ç÷°ü ½ºÅÙÆ® ½ÃÀå

Á¦4Àå ½ÃÀå °³¿ä

  • ¼­·Ð
    • Ç÷°ü ½ºÅÙÆ® ½ÃÀå ¼­·Ð
    • ¾÷°è ÁøÈ­/¹ßÀü
  • °³¿ä
  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ½ÃÀå ±âȸ
  • ¼¼°èÀÇ Ç÷°ü ½ºÅÙÆ® ½ÃÀå ºÐ¼®°ú ¿¹Ãø
    • ½ÃÀå ¸ÅÃâ ¿¹Ãø

Á¦5Àå ÁÖ¿ä ÀλçÀÌÆ®

  • ÁÖ¿ä ÇÕº´°ú Àμö
  • ±â¼ú Áøº¸
  • ¼¼°è ÁÖ¿ä ±¹°¡ÀÇ Áúȯ À¯º´·ü°ú ¹ß»ý·ü
  • Ç÷°ü ½ºÅÙÆ® Á¦Ç° ¸ÅÇÎ

Á¦6Àå ¼¼°èÀÇ Ç÷°ü ½ºÅÙÆ® ½ÃÀå ºÐ¼®°ú ¿¹Ãø : Á¾·ùº°

  • ¼­·Ð°ú Á¤ÀÇ
  • ÁÖ¿ä Á¶»ç °á°ú/¹ßÀü
  • ½ÃÀå ±Ô¸ð ¿¹Ãø : Á¾·ùº°(±Ý¾× ±âÁØ)
    • °ü»óµ¿¸Æ ½ºÅÙÆ®
    • ¸»ÃÊÇ÷°ü ½ºÅÙÆ®
    • ½Å°æÇ÷°ü ½ºÅÙÆ®
  • ½ÃÀå ¸Å·Â : Á¾·ùº°

Á¦7Àå ¼¼°èÀÇ Ç÷°ü ½ºÅÙÆ® ½ÃÀå ºÐ¼®°ú ¿¹Ãø : µô¸®¹ö¸® ¹æ¹ýº°

  • ¼­·Ð°ú Á¤ÀÇ
  • ÁÖ¿ä Á¶»ç °á°ú/¹ßÀü
  • ½ÃÀå ±Ô¸ð ¿¹Ãø : µô¸®¹ö¸® ¹æ¹ýº°(±Ý¾× ±âÁØ)
    • dz¼± È®ÀåÇü ½ºÅÙÆ®
    • ÀÚ±â È®ÀåÇü ½ºÅÙÆ®
  • ½ÃÀå ¸Å·Â : µô¸®¹ö¸® ¹æ¹ýº°

Á¦8Àå ¼¼°èÀÇ Ç÷°ü ½ºÅÙÆ® ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ¼ÒÀ纰

  • ¼­·Ð°ú Á¤ÀÇ
  • ÁÖ¿ä Á¶»ç °á°ú/¹ßÀü
  • ½ÃÀå ±Ô¸ð ¿¹Ãø : ¼ÒÀ纰(±Ý¾× ±âÁØ)
    • ÄÚ¹ßÆ®Å©·Ò ½ºÅÙÆ®
    • Ç÷¡Æ¼³ÑÅ©·Ò ½ºÅÙÆ®
    • ´ÏƼ³î ½ºÅÙÆ®
    • ½ºÅ×Àθ®½º°­ ½ºÅÙÆ®
    • »ýüÈí¼ö¼º Æú¸®¸Ó ½ºÅÙÆ®
  • ½ÃÀå ¸Å·Â : ¼ÒÀ纰

Á¦9Àå ¼¼°èÀÇ Ç÷°ü ½ºÅÙÆ® ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°

  • ¼­·Ð°ú Á¤ÀÇ
  • ÁÖ¿ä Á¶»ç °á°ú/¹ßÀü
  • ½ÃÀå ±Ô¸ð ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°(±Ý¾× ±âÁØ)
    • º´¿ø
    • ½ÉÀå ¼¾ÅÍ
    • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • ½ÃÀå ¸Å·Â : ÃÖÁ¾»ç¿ëÀÚº°

Á¦10Àå ¼¼°èÀÇ Ç÷°ü ½ºÅÙÆ® ½ÃÀå ºÐ¼®°ú ¿¹Ãø : Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ½ÃÀå ±Ô¸ð ¿¹Ãø : Áö¿ªº°(±Ý¾× ±âÁØ)
    • ºÏ¹Ì
    • À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ½ÃÀå ¸Å·Â : Áö¿ªº°

Á¦11Àå ºÏ¹ÌÀÇ Ç÷°ü ½ºÅÙÆ® ½ÃÀå ºÐ¼®°ú ¿¹Ãø

  • ¼­·Ð
    • ÁÖ¿ä Á¶»ç °á°ú
  • ½ÃÀå ±Ô¸ð ¿¹Ãø : Á¾·ùº°(±Ý¾× ±âÁØ)
    • °ü»óµ¿¸Æ ½ºÅÙÆ®
    • ¸»ÃÊÇ÷°ü ½ºÅÙÆ®
    • ½Å°æÇ÷°ü ½ºÅÙÆ®
  • ½ÃÀå ±Ô¸ð ¿¹Ãø : µô¸®¹ö¸® ¹æ¹ýº°(±Ý¾× ±âÁØ)
    • dz¼± È®ÀåÇü ½ºÅÙÆ®
    • ÀÚ±â È®ÀåÇü ½ºÅÙÆ®
  • ½ÃÀå ±Ô¸ð ¿¹Ãø : ¼ÒÀ纰(±Ý¾× ±âÁØ)
    • ÄÚ¹ßÆ®Å©·Ò ½ºÅÙÆ®
    • Ç÷¡Æ¼³ÑÅ©·Ò ½ºÅÙÆ®
    • ´ÏƼ³î ½ºÅÙÆ®
    • ½ºÅ×Àθ®½º°­ ½ºÅÙÆ®
    • »ýüÈí¼ö¼º Æú¸®¸Ó ½ºÅÙÆ®
  • ½ÃÀå ±Ô¸ð ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°(±Ý¾× ±âÁØ)
    • º´¿ø
    • ½ÉÀå ¼¾ÅÍ
    • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • ½ÃÀå ±Ô¸ð ¿¹Ãø : ±¹°¡º°(±Ý¾× ±âÁØ)
    • ¹Ì±¹
    • ij³ª´Ù
  • ½ÃÀå ¸Å·Â ºÐ¼®
    • Á¾·ùº°
    • µô¸®¹ö¸® ¹æ¹ýº°
    • ¼ÒÀ纰
    • ÃÖÁ¾»ç¿ëÀÚº°
    • ±¹°¡º°

Á¦12Àå À¯·´ÀÇ Ç÷°ü ½ºÅÙÆ® ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦13Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ç÷°ü ½ºÅÙÆ® ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦14Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ Ç÷°ü ½ºÅÙÆ® ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦15Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Ç÷°ü ½ºÅÙÆ® ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦16Àå °æÀï »óȲ

  • ½ÃÀå ÁøÃâ ±â¾÷ : °æÀï ¸ÅÆ®¸¯½º(±â¾÷ Tier ¹× ±Ô¸ðº°)
  • ½ÃÀå Á¡À¯À² ºÐ¼® : ±â¾÷º°
  • ±â¾÷ °³¿ä
    • Abbott Vascular(Abbott Laboratories)
    • Cordis Corporation(A Cardinal Health Company)
    • Medtronic
    • Boston Scientific Corporation
    • BIOTRONIK AG
    • Lifetech Scientific
    • CR Bard, Inc.(Becton, Dickinson and Company)
    • Biosensors International Group, Ltd.
    • Cook Medical
    • WL Gore & Associates, Inc.
KSM 20.08.28

List of Tables

  • Table 01: Global Vascular Stents Market Value (US$ Mn) Forecast, by Type, 2017-2027
  • Table 02: Global Vascular Stents Market Value (US$ Mn) Forecast, by Coronary Artery Stents, 2017-2027
  • Table 03: Global Vascular Stents Market Value (US$ Mn) Forecast, by Peripheral Vascular Stents, 2017-2027
  • Table 04: Global Vascular Stents Market Value (US$ Mn) Forecast, by Delivery Method, 2017-2027
  • Table 05: Global Vascular Stents Market Value (US$ Mn) Forecast, by Material, 2017-2027
  • Table 06: Global Vascular Stents Market Value (US$ Mn) Forecast, by End-user, 2017-2027
  • Table 07: Global Vascular Stents Market Value (US$ Mn) Forecast, by Region, 2017-2027
  • Table 08: North America Vascular Stents Market Value (US$ Mn) Forecast, by Country, 2017-2027
  • Table 09: North America Vascular Stents Market Value (US$ Mn) Forecast, by Type, 2017-2027
  • Table 10: North America Vascular Stents Market Value (US$ Mn) Forecast, by Coronary Artery Stents, 2017-2027
  • Table 11: North America Vascular Stents Market Value (US$ Mn) Forecast, by Peripheral Vascular Stents, 2017-2027
  • Table 12: North America Vascular Stents Market Value (US$ Mn) Forecast, by Delivery Method, 2017-2027
  • Table 13: Global Vascular Stents Market Value (US$ Mn) Forecast, by Material, 2017-2027
  • Table 14: North America Vascular Stents Market Value (US$ Mn) Forecast, by End-user, 2017-2027
  • Table 15: Europe Vascular Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 16: Europe Vascular Stents Market Value (US$ Mn) Forecast, by Type, 2017-2027
  • Table 17: Europe Vascular Stents Market Value (US$ Mn) Forecast, by Coronary Artery Stents, 2017-2027
  • Table 18: Europe Vascular Stents Market Value (US$ Mn) Forecast, by Peripheral Vascular Stents, 2017-2027
  • Table 19: Europe Vascular Stents Market Value (US$ Mn) Forecast, by Delivery Method, 2017-2027
  • Table 20: Global Vascular Stents Market Value (US$ Mn) Forecast, by Material, 2017-2027
  • Table 21: Europe Vascular Stents Market Value (US$ Mn) Forecast, by End-user, 2017-2027
  • Table 22: Asia Pacific Vascular Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 23: Asia Pacific Vascular Stents Market Value (US$ Mn) Forecast, by Type, 2017-2027
  • Table 24: Asia Pacific Vascular Stents Market Value (US$ Mn) Forecast, by Coronary Artery Stents, 2017-2027
  • Table 25: Asia Pacific Vascular Stents Market Value (US$ Mn) Forecast, by Peripheral Vascular Stents, 2017-2027
  • Table 26: Asia Pacific Vascular Stents Market Value (US$ Mn) Forecast, by Delivery Method, 2017-2027
  • Table 27: Asia Pacific Vascular Stents Market Value (US$ Mn) Forecast, by Material, 2017-2027
  • Table 28: Asia Pacific Vascular Stents Market Value (US$ Mn) Forecast, by End-user, 2017-2027
  • Table 29: Latin America Vascular Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 30: Latin America Vascular Stents Market Value (US$ Mn) Forecast, by Type, 2017-2027
  • Table 31: Latin America Vascular Stents Market Value (US$ Mn) Forecast, by Coronary Artery Stents, 2017-2027
  • Table 32: Latin America Vascular Stents Market Value (US$ Mn) Forecast, by Peripheral Vascular Stents, 2017-2027
  • Table 33: Latin America Vascular Stents Market Value (US$ Mn) Forecast, by Delivery Method, 2017-2027
  • Table 34: Latin America Vascular Stents Market Value (US$ Mn) Forecast, by Material, 2017-2027
  • Table 35: Latin America Vascular Stents Market Value (US$ Mn) Forecast, by End-user, 2017-2027
  • Table 36: Middle East & Africa Vascular Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 37: Middle East & Africa Vascular Stents Market Value (US$ Mn) Forecast, by Type, 2017-2027
  • Table 38: Middle East & Africa Vascular Stents Market Value (US$ Mn) Forecast, by Coronary Artery Stents, 2017-2027
  • Table 39: Middle East & Africa Vascular Stents Market Value (US$ Mn) Forecast, by Peripheral Vascular Stents, 2017-2027
  • Table 40: Middle East & Africa Vascular Stents Market Value (US$ Mn) Forecast, by Delivery Method, 2017-2027
  • Table 41: Middle East & Africa Vascular Stents Market Value (US$ Mn) Forecast, by Material, 2017-2027
  • Table 42: Middle East & Africa Vascular Stents Market Value (US$ Mn) Forecast, by End-user, 2017-2027

List of Figures

  • Figure 01: Global Vascular Stents Market Value (US$ Mn) Forecast, 2017-2027
  • Figure 02: Global Vascular Stents Market Value Share, by Type, 2018
  • Figure 03: Global Vascular Stents Market Value Share, by Delivery Method, 2018
  • Figure 04: Global Vascular Stents Market Value Share, by Material, 2018
  • Figure 05: Global Vascular Stents Market Value Share, by End-user, 2018
  • Figure 06: Global Vascular Stents Market Value Share, by region, 2018
  • Figure 07: Global Vascular Stents Market Value Share Analysis, by Type, 2018 and 2027
  • Figure 08: Global Vascular Stents Market Attractiveness Analysis, by Type, 2019-2027
  • Figure 09: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Coronary Artery Stents , 2017-2027
  • Figure 10: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Peripheral Vascular Stents, 2017-2027
  • Figure 11: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Neurovascular Stents, 2017-2027
  • Figure 12: Global Vascular Stents Market Value Share Analysis, by Delivery Method, 2018 and 2027
  • Figure 13: Global Vascular Stents Market Attractiveness Analysis, by Delivery Method, 2019-2027
  • Figure 14: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Balloon Expandable Stents, 2017-2027
  • Figure 15: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Self-expanding Stents, 2017-2027
  • Figure 16: Global Vascular Stents Market Value Share Analysis, by Material, 2018 and 2027
  • Figure 17: Global Vascular Stents Market Attractiveness Analysis, by Material, 2019-2027
  • Figure 18: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Cobalt-Chromium Stent, 2017-2027
  • Figure 19: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Platinum-Chromium Stent, 2017-2027
  • Figure 20: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Nitinol Stent, 2017-2027
  • Figure 21: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Stainless Steel Stent, 2017-2027
  • Figure 22: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Bioresorbable Polymer Stent, 2017-2027
  • Figure 23: Global Vascular Stents Market Value Share Analysis, by End-user, 2018 and 2027
  • Figure 24: Global Vascular Stents Market Attractiveness Analysis, by End-user, 2019-2027
  • Figure 25: Global Vascular Stents Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Hospitals, 2017-2027
  • Figure 26: Global Vascular Stents Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Cardiac Centers, 2017-2027
  • Figure 27: Global Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Ambulatory Surgical Centers, 2017-2027
  • Figure 28: Global Vascular Stents Market Value Share, by Region, 2018 and 2027
  • Figure 29: Global Vascular Stents Market Attractiveness, by Region, 2019-2027
  • Figure 30: North America Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 31: North America Vascular Stents Market Value Share (%) Analysis, by Country, 2018 & 2027
  • Figure 32: North America Vascular Stents Market Attractiveness Analysis, by Country, 2019?2027
  • Figure 33: North America Vascular Stents Market Value Share Analysis, by Type, 2018 and 2027
  • Figure 34: North America Vascular Stents Market Attractiveness Analysis, by Type, 2019-2027
  • Figure 35: North America Vascular Stents Market Value Share Analysis, by Delivery Method, 2018 and 2027
  • Figure 36: North America Vascular Stents Market Attractiveness Analysis, by Delivery Method, 2019-2027
  • Figure 37: North America Vascular Stents Market Value Share Analysis, by Material, 2018 and 2027
  • Figure 38: North America Vascular Stents Market Attractiveness Analysis, by Material, 2019-2027
  • Figure 39: North America Vascular Stents Market Value Share Analysis, by End-user, 2018 and 2027
  • Figure 40: North America Vascular Stents Market Attractiveness Analysis, by End-user, 2019-2027
  • Figure 41: Europe Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 42: Europe Vascular Stents Market Value Share (%) Analysis, by Country/Sub-region, 2018 & 2027
  • Figure 43: Europe Vascular Stents Market Attractiveness Analysis, by Country/Sub-region, 2019?2027
  • Figure 44: Europe Vascular Stents Market Value Share Analysis, by Type, 2018 and 2027
  • Figure 45: Europe Vascular Stents Market Attractiveness Analysis, by Type, 2019-2027
  • Figure 46: Europe Vascular Stents Market Value Share Analysis, by Delivery Method, 2018 and 2027
  • Figure 47: Europe Vascular Stents Market Attractiveness Analysis, by Delivery Method, 2019-2027
  • Figure 48: Europe Vascular Stents Market Value Share Analysis, by Material, 2018 and 2027
  • Figure 49: Europe Vascular Stents Market Attractiveness Analysis, by Material, 2019-2027
  • Figure 50: Europe Vascular Stents Market Value Share Analysis, by End-user, 2018 and 2027
  • Figure 51: Europe Vascular Stents Market Attractiveness Analysis, by End-user, 2019-2027
  • Figure 52: Asia Pacific Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 53: Asia Pacific Vascular Stents Market Value Share (%) Analysis, by Country/Sub-region, 2018 & 2027
  • Figure 54: Asia Pacific Vascular Stents Market Attractiveness Analysis, by Country/Sub-region, 2019?2027
  • Figure 55: Asia Pacific Vascular Stents Market Value Share Analysis, by Type, 2018 and 2027
  • Figure 56: Asia Pacific Vascular Stents Market Attractiveness Analysis, by Type, 2019-2027
  • Figure 57: Asia Pacific Vascular Stents Market Value Share Analysis, by Delivery Method, 2018 and 2027
  • Figure 58: Asia Pacific Vascular Stents Market Attractiveness Analysis, by Delivery Method, 2019-2027
  • Figure 59: Asia Pacific Vascular Stents Market Value Share Analysis, by Material, 2018 and 2027
  • Figure 60: Asia Pacific Vascular Stents Market Attractiveness Analysis, by Material, 2019-2027
  • Figure 61: Asia Pacific Vascular Stents Market Value Share Analysis, by End-user, 2018 and 2027
  • Figure 62: Asia Pacific Vascular Stents Market Attractiveness Analysis, by End-user, 2019-2027
  • Figure 63: Latin America Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 64: Latin America Vascular Stents Market Value Share (%) Analysis, by Country/Sub-region, 2018 & 2027
  • Figure 65: Latin America Vascular Stents Market Attractiveness Analysis, by Country/Sub-region, 2019?2027
  • Figure 66: Latin America Vascular Stents Market Value Share Analysis, by Type, 2018 and 2027
  • Figure 67: Latin America Vascular Stents Market Attractiveness Analysis, by Type, 2019-2027
  • Figure 68: Latin America Vascular Stents Market Value Share Analysis, by Delivery Method, 2018 and 2027
  • Figure 69: Latin America Vascular Stents Market Attractiveness Analysis, by Delivery Method, 2019-2027
  • Figure 70: Latin America Vascular Stents Market Value Share Analysis, by Material, 2018 and 2027
  • Figure 71: Latin America Vascular Stents Market Attractiveness Analysis, by Material, 2019-2027
  • Figure 72: Latin America Vascular Stents Market Value Share Analysis, by End-user, 2018 and 2027
  • Figure 73: Latin America Vascular Stents Market Attractiveness Analysis, by End-user, 2019-2027
  • Figure 74: Middle East & Africa Vascular Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027
  • Figure 75: Middle East & Africa Vascular Stents Market Value Share (%) Analysis, by Country/Sub-region, 2018 & 2027
  • Figure 76: Middle East & Africa Vascular Stents Market Attractiveness Analysis, by Country/Sub-region, 2019?2027
  • Figure 77: Middle East & Africa Vascular Stents Market Value Share Analysis, by Type, 2018 and 2027
  • Figure 78: Middle East & Africa Vascular Stents Market Attractiveness Analysis, by Type, 2019-2027
  • Figure 79: Middle East & Africa Vascular Stents Market Value Share Analysis, by Delivery Method, 2018 and 2027
  • Figure 80: Middle East & Africa Vascular Stents Market Attractiveness Analysis, by Delivery Method, 2019-2027
  • Figure 81: Middle East & Africa Vascular Stents Market Value Share Analysis, by Material, 2018 and 2027
  • Figure 82: Middle East & Africa Vascular Stents Market Attractiveness Analysis, by Material, 2019-2027
  • Figure 83: Middle East & Africa Vascular Stents Market Value Share Analysis, by End-user, 2018 and 2027
  • Figure 84: Middle East & Africa Vascular Stents Market Attractiveness Analysis, by End-user, 2019-2027

Title:
Vascular Stents Market (Type: Coronary Artery Stents [Bare Metal Stents, Bioresorbable Stents, Covered Stents, and Drug Eluting Stents], Peripheral Vascular Stents [Fem-pop Artery Stents, Iliac Artery Stents, and Infrapop Artery Stents], and Neurovascular Stents; Delivery Method: Balloon Expandable Stents and Self-expanding Stents; Material: Cobalt-Chromium Stent, Platinum-Chromium Stent, Nitinol Stent, Stainless Steel Stent, and Bioresorbable Polymer Stent; End User: Hospitals, Cardiac Centers, and Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027.

Scope of the Report

TMR's report on the vascular stents market studies the past as well as the current growth trends and opportunities, to gain valuable insights of these indicators for the market over the forecast period from 2019 to 2027. The report provides the overall revenue of the global vascular stents market for the period 2017-2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) of the global vascular stents market for the forecast period 2019-2027.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the vascular stents market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approach to study various phenomena in the vascular stents market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the vascular stents market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the vascular stents market.

The report also delves into the competition landscape of the vascular stents market. Key players operating in the vascular stents market are identified and each one of these is profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the vascular stents market that are profiled in this report.

Key Questions Answered:

  • How does the development of vascular stents provide scope of growth in the vascular stents market?
  • How alliances and partnerships between players are widening the scope of new line of technologies for vascular stents?
  • What are the revenue share projections of key segments under various criteria in the vascular stents market during the forecast period?
  • Which segment is likely to register leading revenue until the end of the forecast period in 2027?
  • How is the evolving health care system in developing countries of Asia Pacific making an impact on the overall vascular stents market?

Research Objectives and Research Approach

The comprehensive report on the vascular stents market begins with an overview of the market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study and healthcare compliances laid down by accredited agencies in the purview of line of procedure for vascular stents.

For reading comprehensibility, the report is compiled in a chapter-wise layout, with each section further divided into smaller sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the vascular stents market in terms of type, delivery method, material, end user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2027 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the vascular stents market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Vascular Stents Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Vascular Stents Market Introduction
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Vascular Stents Market Analysis and Forecast, 2017-2027
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Key Mergers & Acquisitions
  • 5.2. Technological Advancements
  • 5.3. Disease Prevalence & Incidence Rate globally with key countries
  • 5.4. Vascular Stents Product Mapping

6. Global Vascular Stents Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Type, 2017-2027
    • 6.3.1. Coronary Artery Stents
      • 6.3.1.1. Bare Metal Stents
      • 6.3.1.2. Bioresorbable Stents
      • 6.3.1.3. Covered Stents
      • 6.3.1.4. Drug Eluting Stents
    • 6.3.2. Peripheral Vascular Stents
      • 6.3.2.1. Fem-pop Artery Stents
      • 6.3.2.2. Iliac Artery Stents
      • 6.3.2.3. Infrapop Artery Stents
    • 6.3.3. Neurovascular Stents
  • 6.4. Market Attractiveness, by Type

7. Global Vascular Stents Market Analysis and Forecast, by Delivery Method

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Delivery Method, 2017-2027
    • 7.3.1. Balloon Expandable Stents
    • 7.3.2. Self-expanding Stents
  • 7.4. Market Attractiveness, by Delivery Method

8. Global Vascular Stents Market Analysis and Forecast, by Material

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Material, 2017-2027
    • 8.3.1. Cobalt-Chromium Stent
    • 8.3.2. Platinum-Chromium Stent
    • 8.3.3. Nitinol Stent
    • 8.3.4. Stainless Steel Stent
    • 8.3.5. Bioresorbable Polymer Stent
  • 8.4. Market Attractiveness, by Material

9. Global Vascular Stents Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2027
    • 9.3.1. Hospitals
    • 9.3.2. Cardiac Centers
    • 9.3.3. Ambulatory Surgical Centers
  • 9.4. Market Attractiveness, by End-user

10. Global Vascular Stents Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness, by Region

11. North America Vascular Stents Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Type, 2017-2027
    • 11.2.1. Coronary Artery Stents
      • 11.2.1.1. Bare Metal Stents
      • 11.2.1.2. Bioresorbable Stents
      • 11.2.1.3. Covered Stents
      • 11.2.1.4. Drug Eluting Stents
    • 11.2.2. Peripheral Vascular Stents
      • 11.2.2.1. Fem-pop Artery Stents
      • 11.2.2.2. Iliac Artery Stents
      • 11.2.2.3. Infrapop Artery Stents
    • 11.2.3. Neurovascular Stents
  • 11.3. Market Value Forecast, by Delivery Method, 2017-2027
    • 11.3.1. Balloon Expandable Stents
    • 11.3.2. Self-expanding Stents
  • 11.4. Market Value Forecast, by Material, 2017-2027
    • 11.4.1. Cobalt-Chromium Stent
    • 11.4.2. Platinum-Chromium Stent
    • 11.4.3. Nitinol Stent
    • 11.4.4. Stainless Steel Stent
    • 11.4.5. Bioresorbable Polymer Stent
  • 11.5. Market Value Forecast, by End-user, 2017-2027
    • 11.5.1. Hospitals
    • 11.5.2. Cardiac Centers
    • 11.5.3. Ambulatory Surgical Centers
  • 11.6. Market Value Forecast, by Country, 2017-2027
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Type
    • 11.7.2. By Delivery Method
    • 11.7.3. By Material
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Vascular Stents Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Type, 2017-2027
    • 12.2.1. Coronary Artery Stents
      • 12.2.1.1. Bare Metal Stents
      • 12.2.1.2. Bioresorbable Stents
      • 12.2.1.3. Covered Stents
      • 12.2.1.4. Drug Eluting Stents
    • 12.2.2. Peripheral Vascular Stents
      • 12.2.2.1. Fem-pop Artery Stents
      • 12.2.2.2. Iliac Artery Stents
      • 12.2.2.3. Infrapop Artery Stents
    • 12.2.3. Neurovascular Stents
  • 12.3. Market Value Forecast, by Delivery Method, 2017-2027
    • 12.3.1. Balloon Expandable Stents
    • 12.3.2. Self-expanding Stents
  • 12.4. Market Value Forecast, by Material, 2017-2027
    • 12.4.1. Cobalt-Chromium Stent
    • 12.4.2. Platinum-Chromium Stent
    • 12.4.3. Nitinol Stent
    • 12.4.4. Stainless Steel Stent
    • 12.4.5. Bioresorbable Polymer Stent
  • 12.5. Market Value Forecast, by End-user, 2017-2027
    • 12.5.1. Hospitals
    • 12.5.2. Cardiac Centers
    • 12.5.3. Ambulatory Surgical Centers
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2027
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Spain
    • 12.6.5. Italy
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Type
    • 12.7.2. By Delivery Method
    • 12.7.3. By Material
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Vascular Stents Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Type, 2017-2027
    • 13.2.1. Coronary Artery Stents
      • 13.2.1.1. Bare Metal Stents
      • 13.2.1.2. Bioresorbable Stents
      • 13.2.1.3. Covered Stents
      • 13.2.1.4. Drug Eluting Stents
    • 13.2.2. Peripheral Vascular Stents
      • 13.2.2.1. Fem-pop Artery Stents
      • 13.2.2.2. Iliac Artery Stents
      • 13.2.2.3. Infrapop Artery Stents
    • 13.2.3. Neurovascular Stents
  • 13.3. Market Value Forecast, by Delivery Method, 2017-2027
    • 13.3.1. Balloon Expandable Stents
    • 13.3.2. Self-expanding Stents
  • 13.4. Market Value Forecast, by Material, 2017-2027
    • 13.4.1. Cobalt-Chromium Stent
    • 13.4.2. Platinum-Chromium Stent
    • 13.4.3. Nitinol Stent
    • 13.4.4. Stainless Steel Stent
    • 13.4.5. Bioresorbable Polymer Stent
  • 13.5. Market Value Forecast, by End-user, 2017-2027
    • 13.5.1. Hospitals
    • 13.5.2. Cardiac Centers
    • 13.5.3. Ambulatory Surgical Centers
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2027
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Type
    • 13.7.2. By Delivery Method
    • 13.7.3. By Material
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America Vascular Stents Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Type, 2017-2027
    • 14.2.1. Coronary Artery Stents
      • 14.2.1.1. Bare Metal Stents
      • 14.2.1.2. Bioresorbable Stents
      • 14.2.1.3. Covered Stents
      • 14.2.1.4. Drug Eluting Stents
    • 14.2.2. Peripheral Vascular Stents
      • 14.2.2.1. Fem-pop Artery Stents
      • 14.2.2.2. Iliac Artery Stents
      • 14.2.2.3. Infrapop Artery Stents
    • 14.2.3. Neurovascular Stents
  • 14.3. Market Value Forecast, by Delivery Method, 2017-2027
    • 14.3.1. Balloon Expandable Stents
    • 14.3.2. Self-expanding Stents
  • 14.4. Market Value Forecast, by Material, 2017-2027
    • 14.4.1. Cobalt-Chromium Stent
    • 14.4.2. Platinum-Chromium Stent
    • 14.4.3. Nitinol Stent
    • 14.4.4. Stainless Steel Stent
    • 14.4.5. Bioresorbable Polymer Stent
  • 14.5. Market Value Forecast, by End-user, 2017-2027
    • 14.5.1. Hospitals
    • 14.5.2. Cardiac Centers
    • 14.5.3. Ambulatory Surgical Centers
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2027
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Type
    • 14.7.2. By Delivery Method
    • 14.7.3. By Material
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Vascular Stents Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Type, 2017-2027
    • 15.2.1. Coronary Artery Stents
      • 15.2.1.1. Bare Metal Stents
      • 15.2.1.2. Bioresorbable Stents
      • 15.2.1.3. Covered Stents
      • 15.2.1.4. Drug Eluting Stents
    • 15.2.2. Peripheral Vascular Stents
      • 15.2.2.1. Fem-pop Artery Stents
      • 15.2.2.2. Iliac Artery Stents
      • 15.2.2.3. Infrapop Artery Stents
    • 15.2.3. Neurovascular Stents
  • 15.3. Market Value Forecast, by Delivery Method, 2017-2027
    • 15.3.1. Balloon Expandable Stents
    • 15.3.2. Self-expanding Stents
  • 15.4. Market Value Forecast, by Material, 2017-2027
    • 15.4.1. Cobalt-Chromium Stent
    • 15.4.2. Platinum-Chromium Stent
    • 15.4.3. Nitinol Stent
    • 15.4.4. Stainless Steel Stent
    • 15.4.5. Bioresorbable Polymer Stent
  • 15.5. Market Value Forecast, by End-user, 2017-2027
    • 15.5.1. Hospitals
    • 15.5.2. Cardiac Centers
    • 15.5.3. Ambulatory Surgical Centers
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017-2027
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Type
    • 15.7.2. By Delivery Method
    • 15.7.3. By Material
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (by Tier and Size of companies)
  • 16.2. Market Share Analysis by Company (2018)
  • 16.3. Company Profiles
    • 16.3.1. Abbott Vascular (Abbott Laboratories)
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Growth Strategies
      • 16.3.1.3. SWOT Analysis
    • 16.3.2. Cordis Corporation (A Cardinal Health Company)
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Growth Strategies
      • 16.3.2.3. SWOT Analysis
    • 16.3.3. Medtronic
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Growth Strategies
      • 16.3.3.3. SWOT Analysis
    • 16.3.4. Boston Scientific Corporation
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Growth Strategies
      • 16.3.4.3. SWOT Analysis
    • 16.3.5. BIOTRONIK AG
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Growth Strategies
      • 16.3.5.3. SWOT Analysis
    • 16.3.6. Lifetech Scientific
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Growth Strategies
      • 16.3.6.3. SWOT Analysis
    • 16.3.7. C. R. Bard, Inc. (Becton, Dickinson and Company)
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Growth Strategies
      • 16.3.7.3. SWOT Analysis
    • 16.3.8. Biosensors International Group, Ltd.
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Growth Strategies
      • 16.3.8.3. SWOT Analysis
    • 16.3.9. Cook Medical
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Growth Strategies
      • 16.3.9.3. SWOT Analysis
    • 16.3.10. W. L. Gore & Associates, Inc.
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Growth Strategies
      • 16.3.10.3. SWOT Analysis
Back to Top
ÀüÈ­ ¹®ÀÇ
F A Q